Delivery Order SPE2DB22D3004-SPE2DB25FPH58

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,309.74 Firm Fixed Price Delivery Order contract is for the supply of 4566401651 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This federal contract award with ID SPE2DB20D1100|SPE2DB25FA2Y6 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,166.60 firm fixed-price delivery order contract is for the delivery of 4567072342 CLOBAZAM 10 MG TABLET 100S, with a performance period through January 29, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,856.52 firm fixed-price delivery order is for the supply of 4566748542 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUD22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,866.53 firm-fixed-price delivery order is for the supply of 4566924902 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD5WG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,667.79 firm-fixed-price delivery order is for the supply of 4566120947 CLOBAZAM 10 MG TABLET 100S, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,302.58 firm fixed-price delivery order is for the supply of 4566848238 - CLOBAZAM 10 MG TABLET 100S, with a completion date of January 7, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUK63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 Firm Fixed Price Delivery Order contract is for the delivery of 4567140962 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, with an identification number of SPE2DB22D2206|SPE2DB24FHR06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,239.18 firm fixed-price delivery order is for the supply of 4,564,839,957 units of the pharmaceutical product CLOBAZAM 10 MG TABLET 100S. The contract has a completion date of June 10, 2024 and was awarded on June 7, 2024 without any set-aside designation. Amerisourcebergen Drug Corp, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.20 firm fixed-price delivery order is for the supply of 4566691271 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp.'s Corporate Office Division, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of 4565018380 - CLOBAZAM 10 MG TABLET 100S. The $1,555.93 ceiling value Firm Fixed Price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics and acquisition services to the U.S. Armed Forces. The contract has a June 28, 2024 ultimate...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPH58
    Delivery Order

This federal contract award, SPE2DB22D3004|SPE2DB25FPH58, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,846.41 firm fixed-price contract is for the procurement of 4567098084 CLOBAZAM 10 MG TABLET 100S, with a period of performance through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has also maintained a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.

Generated 5/1/25, 10:04 AM